News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,714 Results
Type
Article (39996)
Company Profile (249)
Press Release (664468)
Multimedia
Podcasts (58)
Webinars (14)
Section
Business (204272)
Career Advice (2011)
Deals (35453)
Drug Delivery (95)
Drug Development (81131)
Employer Resources (172)
FDA (16245)
Job Trends (14886)
News (345485)
Policy (32604)
Tag
Academia (2556)
Accelerated approval (9)
Adcomms (22)
Allergies (95)
Alliances (49569)
ALS (108)
Alzheimer's disease (1437)
Antibody-drug conjugate (ADC) (151)
Approvals (16243)
Artificial intelligence (307)
Autoimmune disease (28)
Automation (18)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (120)
Biotechnology (175)
Bladder cancer (93)
Brain cancer (33)
Breast cancer (363)
Cancer (2847)
Cardiovascular disease (209)
Career advice (1681)
Career pathing (30)
CAR-T (183)
CDC (30)
Cell therapy (494)
Cervical cancer (22)
Clinical research (66825)
Collaboration (1011)
Company closure (3)
Compensation (680)
Complete response letters (21)
COVID-19 (2624)
CRISPR (56)
C-suite (321)
Cystic fibrosis (111)
Data (2972)
Decentralized trials (2)
Denatured (20)
Depression (58)
Diabetes (346)
Diagnostics (6421)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (135)
Drug pricing (120)
Drug shortages (28)
Duchenne muscular dystrophy (124)
Earnings (87436)
Editorial (40)
Employer branding (21)
Employer resources (148)
Events (113717)
Executive appointments (845)
FDA (17884)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (925)
Gene editing (129)
Generative AI (22)
Gene therapy (371)
GLP-1 (777)
Government (4499)
Grass and pollen (4)
Guidances (181)
Healthcare (18839)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (146)
Immuno-oncology (8)
Indications (39)
Infectious disease (2795)
Inflammatory bowel disease (147)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (119)
Interviews (312)
IPO (16591)
IRA (44)
Job creations (3636)
Job search strategy (1424)
Kidney cancer (13)
Labor market (52)
Layoffs (491)
Leadership (18)
Legal (7929)
Liver cancer (79)
Lung cancer (399)
Lymphoma (207)
Machine learning (11)
Management (58)
Manufacturing (380)
MASH (90)
Medical device (13456)
Medtech (13461)
Mergers & acquisitions (19574)
Metabolic disorders (844)
Multiple sclerosis (97)
NASH (16)
Neurodegenerative disease (113)
Neuropsychiatric disorders (31)
Neuroscience (2107)
NextGen: Class of 2025 (6516)
Non-profit (4488)
Now hiring (47)
Obesity (424)
Opinion (217)
Ovarian cancer (100)
Pain (104)
Pancreatic cancer (120)
Parkinson's disease (186)
Partnered (22)
Patents (295)
Patient recruitment (160)
Peanut (50)
People (57675)
Pharmaceutical (63)
Pharmacy benefit managers (21)
Phase I (20826)
Phase II (29437)
Phase III (21902)
Pipeline (1618)
Policy (197)
Postmarket research (2563)
Preclinical (8864)
Press Release (64)
Prostate cancer (139)
Psychedelics (35)
Radiopharmaceuticals (253)
Rare diseases (454)
Real estate (5917)
Recruiting (66)
Regulatory (22615)
Reports (50)
Research institute (2324)
Resumes & cover letters (350)
Rett syndrome (9)
RNA editing (8)
RSV (49)
Schizophrenia (86)
Series A (155)
Series B (106)
Service/supplier (11)
Sickle cell disease (60)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3587)
State (2)
Stomach cancer (14)
Supply chain (75)
Tariffs (57)
The Weekly (36)
Vaccines (777)
Venture capital (53)
Weight loss (254)
Women's health (45)
Worklife (16)
Date
Last 7 days (365)
Last 30 days (1764)
Last 365 days (31173)
2025 (16612)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (720)
Alabama (61)
Alaska (7)
Arizona (243)
Arkansas (13)
Asia (38197)
Australia (6231)
California (7400)
Canada (2349)
China (668)
Colorado (320)
Connecticut (316)
Delaware (192)
Europe (82085)
Florida (1114)
Georgia (247)
Hawaii (1)
Idaho (59)
Illinois (636)
India (26)
Indiana (360)
Iowa (16)
Japan (226)
Kansas (108)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1019)
Massachusetts (5501)
Michigan (245)
Minnesota (448)
Mississippi (3)
Missouri (89)
Montana (28)
Nebraska (25)
Nevada (80)
New Hampshire (66)
New Jersey (2066)
New Mexico (28)
New York (2081)
North Carolina (1076)
North Dakota (8)
Northern California (3258)
Ohio (235)
Oklahoma (16)
Oregon (34)
Pennsylvania (1608)
Puerto Rico (17)
Rhode Island (36)
South America (1098)
South Carolina (34)
South Dakota (1)
Southern California (2763)
Tennessee (125)
Texas (1114)
United States (27446)
Utah (219)
Virginia (182)
Washington D.C. (72)
Washington State (629)
West Virginia (4)
Wisconsin (65)
704,714 Results for "neuroptics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
NeurOptics’ Neurological Pupil index™ and Automated Pupillometry Included in Latest European Guidelines for Post-Resuscitation Care
NeurOptics’ Neurological Pupil index™ and automated pupillometry are now included in the updated 2021 European Resuscitation Council and European Society of Intensive Care Medicine Guidelines for post-resuscitation care as an objective measurement supporting neurological prognosis in patients following cardiac arrest.
December 13, 2022
·
5 min read
Biotech Beach
New Clinical Study Shows NeurOptics’ Neurological Pupil Index™, an Important Value for Assessing Brain Injury, is Unaffected by Clinical Intoxication
A newly published clinical study shows that NeurOptics’ Automated Pupillometry and the Neurological Pupil index™ (NPi®) remain unaffected by clinical intoxication, and therefore can be used for rapidly screening emergency room patients for brain injury or neurological injuries regardless of intoxicated state.
January 10, 2023
·
3 min read
Biotech Beach
NeurOptics Expands Globally, Launching NPi®-300 Automated Pupillometer in 15 International Countries
NeurOptics, the worldwide leader in the science of pupillometry, has expanded globally, launching its NPi®-300 in 15 international countries, including the U.K., France, Italy, Germany, Switzerland, Austria, Norway, Sweden, Denmark, Belgium, the Netherlands, Luxembourg, Ireland, Australia and New Zealand.
May 3, 2022
·
4 min read
Biotech Beach
New Peer-Reviewed Study Leverages NeurOptics’ Automated Pupillometry to Measure Pupil Reactivity Differences, an Earlier Indicator of Neurological Injury
A new peer-reviewed study shows that even one occurrence of an abnormal Neurological Pupil index™ (NPi®) differential, measured by NeurOptics’ NPi Pupillometer, can be an early indicator of neurological injury.
September 14, 2022
·
4 min read
Press Releases
CoRegen, Inc. Closes More Than $93 Million Financing
July 10, 2025
·
3 min read
Press Releases
CorMedix inc. Announces Customer Implementation
June 23, 2025
·
3 min read
Press Releases
Spectral Medical Inc. Announces Filing of Base Shelf Prospectus
July 7, 2025
·
4 min read
Press Releases
UTILITY Therapeutics Announces Acquisition by Alembic Pharmaceuticals Inc.
July 3, 2025
·
7 min read
Press Releases
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
July 10, 2025
·
3 min read
Press Releases
Verasonics Announces Partnership With PhotoSound Technologies, Inc.
June 24, 2025
·
3 min read
1 of 70,472
Next
